MicroDAO
With 39 million AMR deaths projected by 2050, MicroDAO unites community governance with sustainable innovation to fund tools, data & AMR solutions. Our marketplace drives core revenue, while the MICRO token empowers contributors, fuels the treasury & ensures impact.
39 Million
total deaths projected by 2050 caused by AMR.
$100 trillion
of cumulative cost AMR may cost to the global economy.
< 1 %
of Global Infectious Disease R&D Funding Allocated to AMR.
With <1% of R&D funds, AMR is neglected. MicroDAO fuels innovation via a self-sustaining model where ecosystem activity generates funding for research into next-gen AMR solutions.
Antimicrobial resistance (AMR) is a growing global health crisis rooted in the biological evolution of bacteria, viruses, fungi, and parasites that develop resistance to drugs meant to eliminate them. ...
Predict & Validate
This area integrates predictive modeling and real-world surveillance to forecast and validate antimicrobial resistance (AMR). Using genomic, clinical, and environmental data across sectors, it identifies emerging trends, resistance hotspots, and supports timely, evidence-based responses. In addition to this, it performs experiments and collects data to validate the predictions to ensure a clear understanding of the impact of resistance
Prevent
This area will focus on the development of interventions to reduce the emergence and spread of antimicrobial resistance (AMR). This includes strategies for antimicrobial stewardship, infection prevention and control, and behavior change, as well as tools to assess and enhance the implementation and impact of these interventions.
Cure
Cure will build on insights from prediction, validation, and prevention efforts to develop economic models and tools that guide cost-effective AMR interventions. It will also accelerate R&D of vaccines, diagnostics, and antimicrobials, supporting sustainable, evidence-informed treatment strategies.
Varun Kothamachu
PhD, Msc and B.Eng
Varun is a life science product specialist combating antimicrobial resistance (AMR). Driven by lessons from the pandemic and...
＠join_microdao on 𝕏
Telegram community
Our value capture strategy is centered on establishing a marketplace for AMR developing and collecting tools, and services.
As AMR continues to rise on global health and policy agendas, the demand for evidence-based, interoperable, and scalable so...
The Lancet
Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050
World Health Organization (WHO)
Global Antimicrobial Resistance and Use Surveillance System (GLASS) report: antibiotic use data for 2022
Center for Global Development (CGD)
